KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Zimmer Biomet Holdings has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.71 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.71 for Q4 2025, down 40.34% from a year ago — trailing twelve months through Dec 2025 was $3.55 (down 20.05% YoY), and the annual figure for FY2025 was $3.55, down 19.86%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.71 at Zimmer Biomet Holdings, down from $1.16 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for ZBH hit a ceiling of $2.0 in Q4 2023 and a floor of -$0.62 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.88 (2024), compared with a mean of $0.8.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 125.16% in 2021 and later soared 1485.71% in 2023.
  • Zimmer Biomet Holdings' EPS (Weighted Average and Diluted) stood at -$0.4 in 2021, then tumbled by 55.0% to -$0.62 in 2022, then skyrocketed by 422.58% to $2.0 in 2023, then plummeted by 40.5% to $1.19 in 2024, then tumbled by 40.34% to $0.71 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.71 (Q4 2025), $1.16 (Q3 2025), and $0.77 (Q2 2025) per Business Quant data.